Topics

"Amgen AMGN Bradway 2019 Results Earnings Call Transcript" Drugs and Medication Database

08:37 EDT 20th September 2019 | BioPortfolio

Here are the most relevant "Amgen AMGN Bradway 2019 Results Earnings Call Transcript" Drugs and Medications that we have found in our database.

More Information about "Amgen AMGN Bradway 2019 Results Earnings Call Transcript" on BioPortfolio

We have published hundreds of Amgen AMGN Bradway 2019 Results Earnings Call Transcript news stories on BioPortfolio along with dozens of Amgen AMGN Bradway 2019 Results Earnings Call Transcript Clinical Trials and PubMed Articles about Amgen AMGN Bradway 2019 Results Earnings Call Transcript for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Amgen AMGN Bradway 2019 Results Earnings Call Transcript Companies in our database. You can also find out about relevant Amgen AMGN Bradway 2019 Results Earnings Call Transcript Drugs and Medications on this site too.

Showing "Amgen AMGN Bradway 2019 Results Earnings Call Transcript" Drugs and Medications, all 21

Possibly Relevant

Corlanor [amgen inc]

These highlights do not include all the information needed to use   CORLANOR safely and effectively. See full prescribing information for   CORLANOR . CORLANOR   ( ivabradine ) t ablets , for oral use Initial U.S. Approval: 2015

Vectibix [amgen inc]

These highlights do not include all the information needed to use VECTIBIX safely and effectively. See full prescribing information for VECTIBIX .     VECTIBIX   (panitumumab)   I njection for intravenous use Initial U.S. Approval: 200 6

Aranesp [amgen inc]

These highlights do not include all the information needed to use ARANESP safely and effectively. See full prescribing information for ARANESP .     ARANESP (darbepoetin alfa )   i njection, for intravenous or subcutaneous use Initial U.S. Approval: 2

Nystatin [lohxa]

Nystatin Oral Suspension, USP

Mvasi [amgen inc]

These highlights do not include all the information needed to use MVASI safely and effectively. See full prescribing information for MVASI .     MVASI (bevacizumab-awwb ) Solution for intravenous infusion Initial U.S. Approval: 2017 MVASI (bevacizumab-

Sensipar [carilion materials management]

These highlights do not include all the information needed to use SENSIPAR safely and effectively. See full prescribing information for SENSIPAR. SENSIPAR (cinacalcet) tablets, for oral use Initial U.S. Approval: 2004

Azelastine hydrochloride [wallace pharmaceuticals inc.]

These highlights do not include all the information needed to use Azelastine Hydrochloride safely and effectively. See full prescribing information for Azelastine Hydrochloride. Azelastine Hydrochloride nasal spray Initial U.S. Approval: 1996

Tasigna [novartis pharmaceuticals corporation]

These highlights do not include all the information needed to use TASIGNA safely and effectively . See full prescribing information for TASIGNA. TASIGNA (nilotinib) c apsules , for oral use Initial U.S. Approval: 2007

Sensipar [physicians total care, inc.]

These highlights do not include all the information needed to use Sensipar safely and effectively. See full prescribing information for Sensipar. Sensipar (cinacalcet) TabletsInitial U.S. Approval: 2004

Imlygic [amgen inc]

These highlights do not include all the information needed to use IMLYGIC   safely and effectively. See full prescribing information for   IMLYGIC .   I MLYGIC   ( talimogene laherparepvec ) Suspension   for intralesional   injection   Initial U.S.

Deltasone [oculus innovative sciences]

Deltasone 20mg prednisone tablets

Meclizine hydrochloride [amneal pharmaceuticals llc]

Meclizine Hydrochloride Tablets, USP (12.5 mg, 25 mg and 50 mg) Rx only

Nplate [amgen inc]

These highlights do not include all the information needed to use NPLATE safely and effectively.   See full prescribing information for NPLATE.   N PLATE (romiplostim) for injection , for subcutaneous use Initial U.S. Approval: 2008

Prolia [amgen inc]

These highlights do not include all the information needed to use PROLIA safely and effectively. See full prescribing information for PROLIA .     Prolia   (denosumab) I njection , for subcutaneous use Initial U.S. Approval:   2010

Diphenhydramine hydrochloride [general injectables and vaccines]

Diphenhydramine Hydrochloride 50mg/ml 1ml

Polymyxin b sulfate and trimethoprim sulfate [pacific pharma, inc.]

POLYMYXIN B SULFATE and TRIMETHOPRIM ophthalmic solution, USP sterile

Epogen [amgen inc]

These highlights do not include all the information needed to use E POGEN safely and effectively. See full prescribing information for E POGEN .    Epogen (epoetin alfa)   i njection , for intravenous or subcutaneous use Initial U.S. Approval: 1989

Parsabiv [amgen inc]

These highlights do not include all the information needed to use PARSABIV safely and effectively. See full prescribing information for PARSABIV.     PARSABIV (etelcalcetide) injection, for intravenous use Initial U.S. Approval: 2017

Compressed gas, n.o.s. [norco, inc.]

NA

Neupogen [physicians total care, inc.]

NA

Sensipar [state of florida doh central pharmacy]

Sensipar (cinacalcet) Tablets



Quick Search